The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Nuclear accumulation of p53 protein is mediated by several nuclear localization signals and plays a role in tumorigenesis.
Open accessAbstract
The basic carboxy terminus of p53 plays an important role in directing the protein into the nuclear compartment. The C terminus of the p53 molecule contains a cluster of several nuclear localization signals (NLSs) that mediate the migration of the protein into the cell nucleus. NLSI, the most active domain, is highly conserved in genetically diverged species and shares perfect homology with consensus NLS sequences found in other nuclear proteins. The other two NLSs, II and III, appear to be less effective and less conserved. Although nuclear localization is dictated primarily by the NLSs inherent in the primary amino acid sequence, the actual nuclear homing can be modified by interactions with other proteins expressed in the cell. Comparison between wild-type p53 and naturally occurring mutant p53 showed that both protein categories could migrate into the nucleus of rat primary embryonic fibroblasts by essentially similar mechanisms. Nuclear localization of both proteins was totally dependent on the existence of functional NLS domains. In COS cells, however, we found that NLS-deprived wild-type p53 molecules could migrate into the nucleus by complexing with another nuclear protein, simian virus 40 large-T antigen. Wild-type and mutant p53 proteins differentially complexed with viral or cellular proteins, which may significantly affect the ultimate compartmentalization of p53 in the cell; this finding suggests that the actual subcellular compartmentalization of proteins may differ in various cell type milieux and may largely be affected by the ability of these proteins to complex with other proteins expressed in the cell. Experiments designed to test the physiological significance of p53 subcellular localization indicated that nuclear localization of mutant p53 is essential for this protein to enhance the process of malignant transformation of partially transformed cells, suggesting that p53 functions within the cell nucleus.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961
A new technique for the assay of infectivity of human adenovirus 5 DNA
Graham, F. L., & van der Eb, A. J. (1973) · Virology · doi:10.1016/0042-6822(73)90341-3 · Cited by 9,451
Kessler, S. W. (1975) · The Journal of Immunology · doi:10.4049/jimmunol.115.6.1617 · Cited by 2,915
Mutations in the p53 gene occur in diverse human tumour types
Nigro, J. M., Baker, S. J., Preisinger, A. C., Jessup, J. M., Hosteller, R., Cleary, K., Signer, S. H., Davidson, N., Baylin, S., Devilee, P., et al. (1989) · Nature · doi:10.1038/342705a0 · Cited by 2,733
A short amino acid sequence able to specify nuclear location
Kalderon, D., Roberts, B. L., Richardson, W. D., & Smith, A. E. (1984) · Cell · doi:10.1016/0092-8674(84)90457-4 · Cited by 2,507
T antigen is bound to a host protein in SY40-transformed cells
LANE, D. P., & CRAWFORD, L. V. (1979) · Nature · doi:10.1038/278261a0 · Cited by 2,394
Chromosome 17 Deletions and p53 Gene Mutations in Colorectal Carcinomas
Baker, S. J., Fearon, E. R., Nigro, J. M., Hamilton, S. R., Preisinger, A. C., Jessup, J. M., vanTuinen, P., Ledbetter, D. H., Barker, D. F., Nakamura, Y., et al. (1989) · Science · doi:10.1126/science.2649981 · Cited by 2,066
The p53 proto-oncogene can act as a suppressor of transformation
Finlay, C. A., Hinds, P. W., & Levine, A. J. (1989) · Cell · doi:10.1016/0092-8674(89)90045-7 · Cited by 1,987
Linzer, D. I. H., & Levine, A. J. (1979) · Cell · doi:10.1016/0092-8674(79)90293-9 · Cited by 1,813
Sequence requirements for nuclear location of simian virus 40 large-T antigen
Kalderon, D., Richardson, W. D., Markham, A. F., & Smith, A. E. (1984) · Nature · doi:10.1038/311033a0 · Cited by 1,286
Cited by
Items 201–300 of 358
What is the potential of p53 isoforms as a predictive biomarker in the treatment of cancer?
Hayman, L., Chaudhry, W. R., Ревин, В. В., Zhelev, N., & Bourdon, J. (2018) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2019.1563484 · Cited by 21
Predominant p53 mutations in enzootic bovine leukemic cell lines
Komori, H., Ishiguro, N., Horiuchi, M., Shinagawa, M., & Aida, Y. (1996) · Veterinary Immunology and Immunopathology · doi:10.1016/0165-2427(95)05538-x · Cited by 21
Bybee, A., & Thomas, N. S. B. (1991) · Blood Reviews · doi:10.1016/0268-960x(91)90035-b · Cited by 25
D’Erchia, A. M., Pesole, G., Tullo, A., Saccone, C., & Sbisà, E. (1999) · Genomics · doi:10.1006/geno.1999.5794 · Cited by 21
Hsu, C.-C., & Hu, C. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.294272 · Cited by 21
Identification of the nuclear localization signals within the Epstein–Barr virus EBNA-6 protein
Krauer, K. G., Buck, M., Flanagan, J. M., Belzer, D. K., & Sculley, T. B. (2004) · Journal of General Virology · doi:10.1099/vir.0.19549-0 · Cited by 20
Øster, B., Bundgaard, B. B., Hupp, T. R., & Höllsberg, P. (2007) · Journal of General Virology · doi:10.1099/vir.0.83136-0 · Cited by 20
P53 is transported into the nucleus via an Hsf1-dependent nuclear localization mechanism
Li, Q., & Martinez, J. D. (2010) · Molecular Carcinogenesis · doi:10.1002/mc.20713 · Cited by 20
Stenmark‐Askmalm, M., Carstensen, J. M., Nordenskjöld, B. A., Olsson, B., Rutqvist, L. E., Skoog, L. K., & Stål, O. (2004) · Acta Oncologica · doi:10.1080/02841860410029474 · Cited by 20
Sigal, A., Matas, D., Almog, N., Goldfinger, N., & Rotter, V. (2001) · Oncogene · doi:10.1038/sj.onc.1204724 · Cited by 20
Self-citationClinical and Functional Significance of TP53 Exon 4–Intron 4 Splice Junction Variants
Pinto, E. M., Maxwell, K. N., Halalsheh, H., Phillips, A., Powers, J., MacFarland, S. P., Walsh, M. F., Breen, K. E., Formiga, M. N., Kriwacki, R. W., et al. (2021) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-21-0583 · Cited by 19
Tickets for p53 journey among organelles
Ferecatu, I., Rincheval, V., Mignotte, B., & Vayssiere, J.-L. (2009) · Frontiers in bioscience · doi:10.2741/3524 · Cited by 19
Chan, W. M., & Poon, R. Y. C. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3602 · Cited by 19
Howes, S., Bockus, B. J., & Schaffhausen, B. S. (1996) · Journal of Virology · doi:10.1128/jvi.70.6.3581-3588.1996 · Cited by 19
Loh, L. C., Keeler, V., & Shanley, J. D. (1999) · Virology · doi:10.1006/viro.1999.9700 · Cited by 19
Cellular and molecular advances in elucidating p53 function
Shay, J. W., Werbin, H., Funk, W. D., & Wright, W. E. (1992) · Mutation Research/Reviews in Genetic Toxicology · doi:10.1016/0165-1110(92)90003-r · Cited by 19
Studies on modulation of the activity of tumor suppressor protein p53
Kadaja, L. (2004) · DSpace repository (University of Tartu) · Cited by 219
Li, C.-H., Cheng, Y., Liao, P.-L., & Kang, J. (2010) · Neoplasia · doi:10.1593/neo.91500 · Cited by 18
Rand, A., Glenn, K. S., Alvares, C., White, M. B., Thibodeau, S. M., & Karnes, W. E. (1996) · Cancer Letters · doi:10.1016/s0304-3835(06)80030-3 · Cited by 18
Overholt, S. M., Liu, T.-J., Taylor, D. L., Wang, M., El‐Naggar, A. K., Shillitoe, E. J., Adler‐Storthz, K., John, L. S., Zhang, W., Roth, J. A., et al. (1997) · PubMed · Cited by 18
Identification of genotoxic stress in human cells by fluorescent monitoring of p53 expression
Quiñones, A., & Rainov, N. G. (2001) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/s1383-5718(01)00179-6 · Cited by 19
Cloning and comparative sequence analysis of TP53 in Xiphophorus fish hybrid melanoma models
Kazianis, S., Gan, L., Coletta, L. D., Santi, B., Morizot, D. C., & Nairn, R. S. (1998) · Gene · doi:10.1016/s0378-1119(98)00144-9 · Cited by 18
Tripartite motif-containing protein 26 promotes colorectal cancer growth by inactivating p53
Tan, Z., Ko, H. M., Naji, P., Zhu, R., Wang, J., Huang, S., Zhang, Y., Zeng, S. X., & Lu, H. (2025) · Cell Death and Differentiation · doi:10.1038/s41418-025-01463-1 · Cited by 17
Matissek, K. J., Okal, A., Mossalam, M., & Lim, C. S. (2014) · Pharmaceutical Research · doi:10.1007/s11095-014-1346-y · Cited by 17
Elephant TP53-RETROGENE 9 induces transcription-independent apoptosis at the mitochondria
Preston, A. J., Rogers, A., Sharp, M., Mitchell, G., Toruno, C., Barney, B. B., Donovan, L. N., Bly, J., Kennington, R., Payne, E., et al. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01348-7 · Cited by 16
Species-specific phosphorylation of mouse and rat p53 in simian virus 40-transformed cells
Patschinsky, T., Knippschild, U., & Deppert, W. (1992) · Journal of Virology · doi:10.1128/jvi.66.6.3846-3859.1992 · Cited by 16
Regulating Phase Transition in Neurodegenerative Diseases by Nuclear Import Receptors
Girdhar, A., & Guo, L. E. (2022) · Biology · doi:10.3390/biology11071009 · Cited by 16
The novel p53 isoform “delta p53” is a misfolded protein and does not bind the p21 promoter site
García-Alai, M., Tidow, H., Natan, E., Townsley, F. M., Veprintsev, D. B., & Fersht, A. R. (2008) · Protein Science · doi:10.1110/ps.036996.108 · Cited by 15
Peacock, J. W., & Benchimol, S. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06357.x · Cited by 15
Mutations of the p53 Gene in B-cell Lymphoma
Ichikawa, A., Hotta, T., & Saito, H. (1993) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428199309054727 · Cited by 15
Krois, A. S., Park, S., Martinez-Yamout, M. A., Dyson, H. J., & Wright, P. E. (2022) · Biochemistry · doi:10.1021/acs.biochem.2c00528 · Cited by 14
Normal and malignant growth control by p53
Finlay, C. A. (1993) · Cancer treatment and research · doi:10.1007/978-1-4615-3088-6_17 · Cited by 14
Expression of wild-type and mutant p53 proteins by recombinant vaccinia viruses
Ronen, D., Teitz, Y., Goldfinger, N., & Rotter, V. (1992) · Nucleic Acids Research · doi:10.1093/nar/20.13.3435 · Cited by 14
Self-citationRehberger, P. A., Richter, K. H., Schwartz, D., Goldfinger, N., Oskato, R., Almog, N., Marks, F., & Rotter, V. (1997) · PubMed · Cited by 14
Self-citationDenney, A. S., Weems, A. D., & McMurray, M. A. (2021) · G3 Genes Genomes Genetics · doi:10.1093/g3journal/jkab230 · Cited by 15
Identification of the nuclear localization signal of SALL4B, a stem cell transcription factor
Wu, M., Yang, F., Ren, Z., Jiang, Y., Ma, Y., Chen, C., & Dai, W. H. (2014) · Cell Cycle · doi:10.4161/cc.28418 · Cited by 15
Park, K. C., Choi, E. J., Sang Won, M. I. N., CHUNG, S. S., Kim, H., Suzuki, T., Tanaka, K., & Chung, C. H. (2000) · Biochemical Journal · doi:10.1042/bj3490443 · Cited by 13
Nuclear localization signals in the Xenopus FGF embryonic early response 1 protein
Post, J. N., Gillespie, L. L., & Paterno, G. D. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02653-9 · Cited by 13
Two different forms of p53 localized differently within cells of urogenital tumours
Benninghoff, J., Kartarius, S., Teleb, Z., Selter, H., Unteregger, G., Zwergel, T., Wullich, B., & Montenarh, M. (1999) · Cancer Letters · doi:10.1016/s0304-3835(99)00187-1 · Cited by 13
p53 – ein natürlicher Krebskiller: Einsichten in die Struktur und Therapiekonzepte
Römer, L., Klein, C., Dehner, A., Kessler, H., & Büchner, J. (2006) · Angewandte Chemie · doi:10.1002/ange.200600611 · Cited by 16
Impact of dihydrolipoic acid on mouse embryonic stem cells and related regulatory mechanisms
Chan, W., Houng, W., Lin, C. J., Lee, C., Li, P., Hsieh, J.-T., Shen, J., Yeh, H., & Chang, W. H.-S. (2011) · Environmental Toxicology · doi:10.1002/tox.20700 · Cited by 11
Mice defective in p53 nuclear localization signal 1 exhibit exencephaly
Regeling, A., Armata, H. L., Gallant, J., Jones, S. N., & Sluss, H. K. (2010) · Transgenic Research · doi:10.1007/s11248-010-9468-4 · Cited by 11
Tiralongo, J., Fujita, A., Sato, C., Kitajima, K., Lehmann, F., Oschlies, M., Gerardy‐Schahn, R., & Münster-Kühnel, A. K. (2007) · Glycobiology · doi:10.1093/glycob/cwm064 · Cited by 11
Giant leap for p53, small step for drug design
Anderson, M. E., & Tegtmeyer, P. (1995) · BioEssays · doi:10.1002/bies.950170103 · Cited by 11
P53 protein expression in Hodgkin's disease
Lauritzen, A. F., HOU-JENSEN, K., & Ralfkiaer, E. M. (1993) · Apmis · doi:10.1111/j.1699-0463.1993.tb00166.x · Cited by 11
Abdelmoula-Souissi, S., Delahodde, A., Bolotin‐Fukuhara, M., Gargouri, A. F., & Mokdad‐Gargouri, R. (2011) · APOPTOSIS · doi:10.1007/s10495-011-0607-z · Cited by 11
Maki, C. G. (2010) · Molecular biology intelligence unit · doi:10.1007/978-1-4419-8231-5_8 · Cited by 11
Sugikawa, E., Yazaki, N., Tsunoda, S., Nakanishi, N., & Ohashi, M. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1019 · Cited by 10
Structure and Regulation of Nuclear Localization Signals
Richter, J. D., & Standiford, D. M. (1992) · Elsevier eBooks · doi:10.1016/b978-0-12-252050-1.50011-x · Cited by 10
Epigenetic mechanisms in melanoma development and progression
Joo, H., Olea, X. D., Zhuang, A., Zheng, B., Kim, H., & Ronai, Z. A. (2025) · Trends in cancer · doi:10.1016/j.trecan.2025.04.007 · Cited by 9
Gatekeepers of the Guardian: p53 Regulation by Post-Translational Modification, MDM2 and MDMX
Wahl, G. M., Stommel, J. M., Krummel, K. A., & Wade, M. R. (2005) · Springer eBooks · doi:10.1007/978-1-4020-2922-6_4 · Cited by 10
Potential effects of CRM1 inhibition in mantle cell lymphoma
Zhang, K.-J., & Wang, M. L. (2012) · Chinese Journal of Cancer Research · doi:10.1007/s11670-012-0278-5 · Cited by 8
Węsierska‐Gądek, J. (2018) · Future Medicinal Chemistry · doi:10.4155/fmc-2017-0175 · Cited by 7
The role of the C' terminus of murine p53 in the p53/mdm-2 regulatory loop
Almog, N., Milyavsky, M., Stambolsky, P., Falcovitz, A., Goldfinger, N., & Rotter, V. (2001) · Carcinogenesis · doi:10.1093/carcin/22.5.779 · Cited by 7
Self-citationGuerreiro, A. D. S., Rola, R. C., Almeida, D. V., & Sandrini, J. Z. (2018) · Invertebrate Biology · doi:10.1111/ivb.12205 · Cited by 7
Molecular and Biochemical Techniques for Deciphering p53-MDM2 Regulatory Mechanisms
Karakostis, K., López, I., Peña-Balderas, A. M., Fåhareus, R., & Olivares‐Illana, V. (2020) · Biomolecules · doi:10.3390/biom11010036 · Cited by 7
p53 gene alterations and protein accumulation in colorectal cancer
Bertorelle, R., Esposito, G., Belluco, C., Bonaldi, L., Mistro, A. D., Nitti, D., Lise, M., & Chieco‐Bianchi, L. (1996) · Molecular Pathology · doi:10.1136/mp.49.2.m85 · Cited by 7
Hoi Sang, U., Banaie, A., Rigby, L., & Chen, J. W. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00061-5 · Cited by 7
p53 contains a DNA break-binding motif similar to the functional part of BRCT-related region of Rb
Yamane, K., Katayama, E., & Tsuruo, T. (2001) · Oncogene · doi:10.1038/sj.onc.1204408 · Cited by 11
Nuclear Transport Receptors: Specificity amid Diversity
Yamasaki, L., & Lanford, R. E. (1992) · Elsevier eBooks · doi:10.1016/b978-0-12-252050-1.50012-1 · Cited by 7
Lin, S., YANG, Y.-C., JUNG, J.-H., & Jh, T. (1996) · DNA and Cell Biology · doi:10.1089/dna.1996.15.793 · Cited by 7
Modelling the p53 gene regulatory network.
Brewer, D. S. (2006) · OpenGrey (Institut de l'Information Scientifique et Technique) · Cited by 11
Dasgupta, P. S. (1991) · New York University Press eBooks · Cited by 6
Form of Human p53 Protein during Nuclear Transport in Xenopus laevis Embryos
Hara, T., Arai, K., & Koike, K. (2000) · Experimental Cell Research · doi:10.1006/excr.2000.4926 · Cited by 6
Naji, A. M., Moghaddam, M., Ghaffari, M. R., Irandoost, H. P., Farsad, L. K., Pirseyedi, S. M., Mohammadi, S. A., Ghareyazie, B., & Mardi, M. (2008) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/s1673-8527(08)60083-1 · Cited by 6
Wild-typep53 gene-induced morphological changes and growth suppression in hepatoma cells
Terai, S., Noma, T., Kimura, T., Nakazawa, A., Kurokawa, F., & Okita, K. (1997) · Journal of Gastroenterology · doi:10.1007/bf02934489 · Cited by 6
Identification of two novel isoforms of mouse NUR77 lacking N‐terminal domains
Rehman, S. U., Sarwar, T., Husain, M. A., Ishqi, H. M., & Tabish, M. (2017) · IUBMB Life · doi:10.1002/iub.1605 · Cited by 6
TP53 tumor‐suppressor gene and human carcinogenesis
Basset‐Séguin, N., Molès, J., Mils, V., Dereure, O., & Guilhou, J. J. (1993) · Experimental Dermatology · doi:10.1111/j.1600-0625.1993.tb00016.x · Cited by 6
Jakob, R. (1995) · Preparative Biochemistry · doi:10.1080/10826069508010114 · Cited by 6
McKinney, K. M., & Prives, C. L. (2005) · Springer eBooks · doi:10.1007/978-1-4020-2922-6_2 · Cited by 10
Joerger, A. C., Friedler, A., & Fersht, A. R. (2005) · Springer eBooks · doi:10.1007/978-1-4020-2922-6_17 · Cited by 9
Socioeconomic status, p53 abnormalities, and colorectal cancer.
Vogtmann, E., Shanmugam, C., Katkoori, V. R., Waterbor, J. W., & Manne, U. (2013) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2078-6891.2012.054 · Cited by 5
Tumor-suppressor genes in breast cancer progression
Smith, H. S. (1994) · Cancer treatment and research · doi:10.1007/978-1-4615-2592-9_5 · Cited by 5
Kanezaki, R., Toki, T., Xu, G., Narayanan, R., & Ito, E. (2006) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.209.169 · Cited by 5
Ashcroft, M. A., & Vousden, K. H. (2001) · Humana Press eBooks · doi:10.1007/978-1-59259-230-2_7 · Cited by 5
Lou, S. K., Hodgson, A., Nofech‐Mozes, S., Schwock, J., Olkhov‐Mitsel, E., Mirković, J., & Ghorab, Z. (2022) · Cancer Cytopathology · doi:10.1002/cncy.22642 · Cited by 4
Soluble Guanylate Cyclase β1 Subunit Represses Human Glioblastoma Growth
Xiao, H., Zhu, H., Bögler, O., Mónica, F. Z., Kots, A. Y., Murad, F., & Bian, K. (2023) · Cancers · doi:10.3390/cancers15051567 · Cited by 4
Zhao, W., He, C., Rotter, V., Merrick, B. A., & Selkirk, J. K. (1999) · Cancer Letters · doi:10.1016/s0304-3835(99)00283-9 · Cited by 4
Self-citationHauke, J., Wappenschmidt, B., Faust, U., Niederacher, D., Wiesmüller, L., Schmidt, G., Groß, E., Meindl, A., Gehrig, A., Sutter, C., et al. (2021) · Senologie - Zeitschrift für Mammadiagnostik und -therapie · doi:10.1055/a-1342-5231 · Cited by 6
Alteration in p53 Modulates Glial Proteins in Human Glial Tumour Cells
Hs, U., Banaie, A., Rigby, L., Chen, J., & Meltzer, H. (2000) · Journal of Neuro-Oncology · doi:10.1023/a:1006453316656 · Cited by 4
Pei, L. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.2.1176 · Cited by 4
Mukhopadhyay, T., Maxwell, S. A., & Roth, J. A. (1995) · Molecular biology intelligence unit · doi:10.1007/978-3-662-22275-1_3 · Cited by 4
Bruer, M., Reinhardt, D., Welte, K., & Thakur, B. K. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.02.002 · Cited by 3
Keith, F. J., & Russell, N. H. (1996) · Cancer treatment and research · doi:10.1007/978-1-4613-1261-1_6 · Cited by 3
Biology of p53 and SV40 Large T Association
Montano, X. (2003) · Humana Press eBooks · doi:10.1385/1-59259-117-5:201 · Cited by 3
Wang, S., Cheng, T., Chen, X., Zeng, C., Qin, W., & Xu, Y. (2024) · Clinical Science · doi:10.1042/cs20241144 · Cited by 2
Holoubek, A., Strachotová, D., Wolfová, K., Otevřelová, P., Belejová, S., Röselová, P., Benda, A., Brodská, B., & Heřman, P. (2025) · PLoS ONE · doi:10.1371/journal.pone.0322096 · Cited by 2
Fertilization and embryo development
Kostović‐Knežević, L., & Gajović, S. (2004) · Cited by 2
Tumorvirologie, A. F., & Klotzsche, O. (2005) · Cited by 2
Tung, S.-F., Chuang, J., Lin, C., Lai, M., Wu, C., & Lin, Y.-S. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.12.7748 · Cited by 2
p53 protein biosignatures in acute myeloid leukemia
Ånensen, N. (2006) · NORA - Norwegian Open Research Archives · Cited by 4
Genetic Alterations in Colon Cancer
Nasim, S., & Garrett, C. T. (1995) · Humana Press eBooks · doi:10.1007/978-1-4757-2381-6_6 · Cited by 1
Junk, D. J. (2008) · UA Campus Repository (The University of Arizona) · Cited by 1
Association of Wild-Type P53 with Cell Differentiation: Induction of Pre-b Cell Maturation in Vitro
Rotter, V., Shaulsky, G., & Goldfinger, N. (1993) · Springer eBooks · doi:10.1007/978-3-642-77040-1_20 · Cited by 1
Self-citationA Transgenic Model to Study the Role of Oncogenes and Tumour Suppressor Genes in T-Cell Lymphoma
Blyth, K. (1996) · Enlighten: Theses (The University of Glasgow) · Cited by 1
Boldogh, I. R., Bhakat, K. K., Bocangel, D., Das, G. M., & MITRA, S. P. (2004) · doi:10.1007/978-1-59259-735-2_5 · Cited by 1
Joerger, A. C., Friedler, A., & Fersht, A. R. (2007) · Springer eBooks · doi:10.1007/978-0-387-36534-3_17 · Cited by 1
Tumor suppressor p53 and transcriptional changes in cellular stress responses to UV radiation
Latonen, L. (2003) · Työväentutkimus Vuosikirja
Growth inhibition and apoptosis induction in ovarian cancer cells : molecular mechanisms
Touma, R. (2007) · Publications of the UdS (Saarland University) · doi:10.22028/d291-20963
Vilar, J. B. (2014) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.42.2014.tde-24022015-105346
Metadata
- Authors
- Shaulsky, G., Goldfinger, N., Ben-Ze'ev, A., & Rotter, V
- Affiliations
- Weizmann Institute of Science (IL)
- ORCID
- Shaulsky, G
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 1990-12
- Volume
- 10
- Issue
- 12
- Pages
- 6565-6577
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- PMC
- PMC362933
- OpenAlex
- W1806610286
- Cited by
- 356
- References
- 60
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 1 · 2023: 4 · 2022: 4 · 2021: 6 · 2020: 7 · 2019: 2 · 2018: 5 · 2017: 6 · 2016: 4 · 2015: 5 · 2014: 10 · 2013: 11 · 2012: 5
- FWCI
- 11.81
- Type
- journal article
- Language
- en
- Open access
- green
- pmc.ncbi.nlm.nih.gov
- Locations
- Molecular and Cellular Biology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (publishedVersion)
- Funders
- Princeton University
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Structure and Function
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Structure and Dynamics
- Keywords
- p53, nuclear localization signal, nuclear accumulation, p53 C-terminal domain, SV40 large T antigen, protein-protein interaction, subcellular localization, carcinogenesis, malignant transformation, mutant p53, embryonic fibroblasts
- MeSH terms
- Amino Acid Sequence, Animals, Base Sequence, Cell Line, Cell Nucleus, Cell Transformation, Neoplastic, Chromosome Deletion, Cloning, Molecular, Humans, Molecular Sequence Data, Plasmids, Sequence Homology, Nucleic Acid, Transfection, Signal Transduction, Tumor Suppressor Protein p53, Mutagenesis, Site-Directed, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A second model labelled each claim on 2026-11-15 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.